Skip to content

A study to evaluate the impact of a software to detect eye diseases (Google-ARDA) among people with type 2 diabetes in India.

Effectiveness of Google-Automated Retinal Disease Assessment (ARDA) tool assisted diabetic retinopathy screening program among people with type 2 diabetes in India-A three arm Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047093
Enrollment
1125
Registered
2022-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Automated Retinal Disease Assessment (ARDA) tool assisted diabetic retinopathy screening: Participants get their fundus photos taken by a camera technician. One image (primary field of

Sponsors

Google LLC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: With at least 3 years of diabetes duration from the date of diagnosis and Resident of Delhi-NCR and Willing/able to give consent to participate in the study

Exclusion criteria

Exclusion criteria: Participants who fall under any of the following criteria will be excluded: Previous diagnosis of any Diabetic Retinopathy (DR) Participants with any visual symptoms or conditions (e.g., loss of vision, blurry vision, persistent floaters), other than those corrected with glasses, contact lenses or other refractive corrections Undergone any laser treatment of the retina in the past Undergone any retinal surgeries

Design outcomes

Secondary

MeasureTime frame
Time taken to adhere with referrals to eye specialist (i.e., number of days it took for participants to see ophthalmologists from the date of referral) Measure the impact of enhanced standard care and ARDA on reducing the time between DR screening and start of ophthalmic management of a referable condition Proportion of referred participant, who had received any treatment from ophthalmology facility at three months from the date of referral Participant satisfaction with DR screening and referral (at three months) Timepoint: Three months from the date of referral

Primary

MeasureTime frame
Proportion of participants who had at least one visit at ophthalmology facility (for DR screening/follow up) within three months from the date of referralTimepoint: Three months from the date of referral

Countries

India

Contacts

Public ContactDr Nikhil Tandon

All India Institute of Medical Sciences, New Delhi

nikhil_tandon@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026